If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director/PDMR Shareholding

13 Jul 2010 07:00

RNS Number : 2241P
Chamberlin PLC
13 July 2010
 



CMH

13 July 2010

 

 

Chamberlin plc

 

("Chamberlin" or "the Company")

 

Notification

of

 Interests of Directors and Connected Persons

 

Chamberlin was notified on 12 July 2010 that Mrs A J R Jackson, the wife of Keith Jackson, a Non-executive Director of the Company, has acquired 6,000 new Ordinary 25p Shares in the Company at a purchase price of 81.5p per share.

 

This purchase takes Keith Jackson's beneficial shareholding to 13,525 shares, representing approximately 0.18% of the total issued share capital of the Company.

 

For further information, please contact:

 

Chamberlin plc

T: 01922 707100

Tim Hair, Chief Executive

Mark Bache, Finance Director

Charles Stanley Securities Nominated Adviser

T: 020 7149 6000

Russell Cook / Luke Webster

Biddicks

T: 020 7448 1000

Katie Tzouliadis

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRTMATMBABBFM
Date   Source Headline
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.